Lantern Pharma (LTRN) Return on Equity [ROE] (2021 - 2026)
Lantern Pharma's Return on Equity [ROE] was -13324.87% in Q2 2026, down 13189.13 percentage points from -135.74% a year earlier and down 12998.63 percentage points from the prior quarter.
Powered by 
Analysis
Lantern Pharma (LTRN) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Lantern Pharma came in at -126.55%, down 57.38 percentage points from FY2024.
- Return on Equity [ROE] has now declined for three consecutive years, with a four-year change of -99.10 percentage points (FY2021 to FY2025).
- In earlier years, Return on Equity [ROE] was -69.16% in FY2024 (-33.86 pp), -35.30% in FY2023 (-13.00 pp), -22.30% in FY2022 (+5.14 pp) and -27.44% in FY2021.
- The Q2 2026 figure marks the lowest quarterly Return on Equity [ROE] in data going back to Q3 2021.
- Compared with a year earlier, Return on Equity [ROE] has declined for 16 straight quarters, with an average year-over-year change of -1732.93 percentage points over the last eight quarters.
- Over the past five years, the year-over-year drop in Return on Equity [ROE] ranged from 4.53 percentage points (Q2 2023) to 13189.13 percentage points (Q2 2026).
- Per Business Quant data, LTRN's Return on Equity [ROE] in the three quarters before Q2 2026 was -326.24% (Q1 2026), -217.61% (Q4 2025) and -173.19% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | - |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 4.97% |
| 10 | Lantern Pharma | 7.95 Mn | -28.21 Mn | - | -13,324.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13,324.87% |
| Mar 31, 2026 | -326.24% |
| Dec 31, 2025 | -217.61% |
| Sep 30, 2025 | -173.19% |
| Jun 30, 2025 | -135.74% |
| Mar 31, 2025 | -108.35% |
| Dec 31, 2024 | -89.88% |
| Sep 30, 2024 | -70.74% |
| Jun 30, 2024 | -55.89% |
| Mar 31, 2024 | -48.23% |
| Dec 31, 2023 | -39.65% |
| Sep 30, 2023 | -34.70% |
| Jun 30, 2023 | -29.89% |
| Mar 31, 2023 | -26.40% |
| Dec 31, 2022 | -24.73% |
| Sep 30, 2022 | -23.39% |
| Jun 30, 2022 | -25.36% |
| Mar 31, 2022 | -20.62% |
| Dec 31, 2021 | -15.98% |
| Sep 30, 2021 | -11.64% |
API Access
Lantern Pharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LTRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "LTRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LTRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();